EnACT3, NCT05541107: Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3

ACTRN12619001762145: An interventional study to evaluate the effects of dosages on the Pharmacokinetics (PK, the measure of how the human body processes a substance), Tolerability (how well a substance is tolerated by participants), and Safety of different dosages of Amphotericin B (iCo-019) when given to healthy participants as multiple oral doses.